Margo Georgiadis is a CEO-Partner at Flagship Pioneering and Co-Founder and CEO of Montai Therapeutics. In these roles, Margo brings extensive expertise in technological innovation and high-performance business transformation and leverages her artificial intelligence and machine learning experience to advance biotech innovation. Working with Flagship CEO and Founder Noubar Afeyan and Lord Ara Darzi, she plays an instrumental role in Flagship’s efforts to scale its Preemptive Medicine & Health Initiative and develop new companies aimed at deterring or delaying the onset of disease, improve health outcomes for consumers, corporations, and countries. Margo is an experienced CEO and company builder who has dedicated her career to transforming products and services with data and technology to empower consumers to live better lives, and to deliver outsized growth and returns for investors. Most recently, she served as an Endurance Partner at venture catalyst firm General Catalyst, where she focused on building next-generation healthcare platforms that improve clinical outcomes while making healthcare more consumer-centric, accessible and affordable. Previously, she served as President and CEO of Ancestry where she brought together content, science, and technology to transform Ancestry into the undisputed global leader in family history and consumer genomics.